Jon Jones will officially appear before the California State Athletic Commission at a hearing at the end of this month to determine his punishment for a failed drug test at UFC 214.
Jones’ hearing is listed on the CSAC’s Feb. 27 agenda. The former UFC light heavyweight champion tested positive for the anabolic steroid Turinabol during an in-competion screening in relation to his victory over Daniel Cormier in Anaheim, Calif., on July 29.
The Jackson-Wink MMA product will likely receive a fine and suspension from the CSAC. His third-round technical knockout victory over Cormier was overturned following the positive test.
Meanwhile, Jones is also facing sanctions from USADA for the anti-doping violation. As a second-time offender, “Bones” could receive up to a four-year suspension. He also tested positive for the estrogen blockers clomiphene and Letrozol in an out-of-competition test at UFC 200. Jones was ultimately suspended one year for negligence after proving that the result came from a tainted sexual enhancement pill.
Jones’ manager, Malki Kawa, recently said that he expects his fighter’s case to be resolved in time for the ex-champ to return to the Octagon in 2018.
“If USADA is a respectable organization, which I think that they are, and they take all the information they compiled, all the interviews that they’ve done and all the things they’ve seen, they know for a fact that Jon Jones was not cheating and he was not intentionally taking any type of substance,” Kawa said on “The Luke Thomas Show” on Sirius XM.
“I think they know that and everybody can come to that conclusion based on the circumstances of his situation. That’s the most I am going to say at this point because obviously it’s ongoing. I’d like to say [that there’s] about a 95 percent chance [he fights in 2018].”